2019
The Ethics of Fecal Microbiota Transplant as a Tool for Antimicrobial Stewardship Programs
Murray TS, Herbst J. The Ethics of Fecal Microbiota Transplant as a Tool for Antimicrobial Stewardship Programs. The Journal Of Law, Medicine & Ethics 2019, 47: 541-554. PMID: 31957576, DOI: 10.1177/1073110519897730.Peer-Reviewed Original ResearchMeSH KeywordsAnti-Bacterial AgentsAntimicrobial StewardshipClinical Trials as TopicDrug Resistance, Multiple, BacterialEthics, ClinicalEthics, InstitutionalEthics, ResearchFecal Microbiota TransplantationFemaleHumansMaleConceptsFecal microbiota transplantMultidrug-resistant organismsAntimicrobial stewardship programsMicrobiota transplantStewardship programsCurrent clinical indicationsPublic health threatPatient colonizationSevere recurrentAntibiotic useClinical indicationsResistant organismsAvailable antibioticsHealth threatTransplantAdditional evidenceTherapyInfectionRecurrent
2012
Antimicrobial susceptibility patterns of multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii against carbapenems, colistin, and tigecycline.
Somily AM, Absar MM, Arshad MZ, Al Aska AI, Shakoor ZA, Fatani AJ, Siddiqui YM, Murray TS. Antimicrobial susceptibility patterns of multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii against carbapenems, colistin, and tigecycline. Saudi Medical Journal 2012, 33: 750-5. PMID: 22821309.Peer-Reviewed Original ResearchMeSH KeywordsAcinetobacter baumanniiAnti-Bacterial AgentsCarbapenemsColistinDrug Resistance, Multiple, BacterialMicrobial Sensitivity TestsMinocyclinePseudomonas aeruginosaTigecyclineConceptsA. baumannii strainsA. baumanniiTherapeutic optionsBaumannii strainsMinimum inhibitory concentrationAcinetobacter baumanniiP. aeruginosaMultidrug-resistant Pseudomonas aeruginosaBest therapeutic optionAlternative therapeutic optionMDR A. baumanniiAntimicrobial susceptibility patternsNon-fermenting Gram-negative bacteriaNon-duplicate samplesAntimicrobial agentsPseudomonas aeruginosaSusceptibility patternsE-testBaumanniiColistinTigecyclineAlternative antimicrobial agentsDoripenemCarbapenemsInhibitory concentration